Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03829501
Title Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kymab Limited
Indications

melanoma

lung non-small cell carcinoma

kidney cancer

stomach cancer

hepatocellular carcinoma

Advanced Solid Tumor

cervical cancer

triple-receptor negative breast cancer

pancreatic cancer

esophageal cancer

head and neck squamous cell carcinoma

Therapies

Atezolizumab + KY1044

KY1044

Age Groups: adult | senior
Covered Countries USA | ITA

Facility Status City State Zip Country Details
Kymab investigational site 1102 Recruiting New Haven Connecticut 06510 United States Details
Kymab investigational site 1104 Recruiting Sarasota Florida 34232 United States Details
Kymab investigational site 1103 Recruiting Nashville Tennessee 37203 United States Details
Kymab investigator site 1101 Recruiting Houston Texas 77030 United States Details
Kymab investigational site 3901 Recruiting Milano Italy Details
Kymab investigational site 3903 Recruiting Milano Italy Details
Kymab investigational site 3902 Recruiting Napoli Italy Details
Kymab investigational site 8801 Recruiting Taipei Taiwan Details
Kymab investigational site 4405 Recruiting London United Kingdom Details
Kymab investigational site 4402 Recruiting Manchester United Kingdom Details
Kymab investigational site 4404 Recruiting Oxford United Kingdom Details
Kymab investigational site 4401 Recruiting Sutton United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field